Mortality Risk Reduction With Budesonide/Glycopyrrolate/Formoterol Fumarate Versus Fluticasone Furoate/Umeclidinium/Vilanterol in COPD: A Matching-Adjusted Indirect Comparison of Ethos and Impact
D. Stolz, E. Hermansson, M. Ouwens, B. Singh, A. Sharma, D. Jackson, P. Darken, J. Marshall, H. Müllerová, B. Alcázar Navarrete, R. Russell, M. Han, M. Bafadhel, D. Tansey-Dwyer
{"title":"Mortality Risk Reduction With Budesonide/Glycopyrrolate/Formoterol Fumarate Versus Fluticasone Furoate/Umeclidinium/Vilanterol in COPD: A Matching-Adjusted Indirect Comparison of Ethos and Impact","authors":"D. Stolz, E. Hermansson, M. Ouwens, B. Singh, A. Sharma, D. Jackson, P. Darken, J. Marshall, H. Müllerová, B. Alcázar Navarrete, R. Russell, M. Han, M. Bafadhel, D. Tansey-Dwyer","doi":"10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a2859","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":205419,"journal":{"name":"B22. NEW TREATMENTS AND NOVEL TARGETS FOR COPD AND ALPHA-1","volume":"13 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"B22. NEW TREATMENTS AND NOVEL TARGETS FOR COPD AND ALPHA-1","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a2859","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
